Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

elacytarabine

(EH-luh-sy-TAYR-uh-been)

A drug used to treat advanced acute myeloid leukemia (AML). It is a form of the anticancer drug cytarabine that may work in patients with leukemia that is resistant to cytarabine. Elacytarabine blocks cell division and may kill cancer cells. It is a type of antimetabolite. Also called CP-4055 and Elacyt.

elacytarabine

Search NCI's Dictionary of Cancer Terms